Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Cannabinoids for Knee OA Pain
NCT04992962Phase 2Unknown
- Sponsor
- Pure Green Pharmaceuticals
- Start
- Jul 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, cannabinol, dronabinol in osteoarthritis (OA), sponsored by Pure Green Pharmaceuticals. Status: unknown.
02
Drugs
cannabidiolcannabinoldronabinol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04992962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992962.